Rhythm Biosciences Limited (RHY.AX)
AUD 0.08
(-3.53%)
AUD 0.08
(-3.53%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -6.79 Million AUD | 38.82% |
| 2023 | -11.1 Million AUD | -1.87% |
| 2022 | -11.1 Million AUD | -72.38% |
| 2021 | -6.46 Million AUD | -66.89% |
| 2020 | -3.87 Million AUD | -6.15% |
| 2019 | -2.6 Million AUD | -128.51% |
| 2018 | -1.59 Million AUD | -2114.2% |
| 2017 | 733.39 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -2.76 Million AUD | 0.0% |
| 2024 Q2 | -5.71 Million AUD | 0.0% |
| 2024 FY | - AUD | 26.03% |
| 2023 Q4 | -4.93 Million AUD | 0.0% |
| 2023 Q2 | -6.41 Million AUD | 0.0% |
| 2023 FY | - AUD | -1.87% |
| 2022 Q2 | -6.6 Million AUD | 0.0% |
| 2022 FY | - AUD | -72.38% |
| 2022 Q4 | -4.54 Million AUD | 0.0% |
| 2021 Q2 | -3.05 Million AUD | -215.26% |
| 2021 FY | - AUD | -66.89% |
| 2021 Q1 | -968.47 Thousand AUD | 54.87% |
| 2021 Q4 | -4.53 Million AUD | 0.0% |
| 2020 Q4 | -2.14 Million AUD | -121.58% |
| 2020 FY | - AUD | -6.15% |
| 2020 Q2 | -1.87 Million AUD | 0.0% |
| 2020 Q3 | -968.47 Thousand AUD | 48.33% |
| 2019 Q2 | -1.52 Million AUD | 0.0% |
| 2019 FY | - AUD | -128.51% |
| 2019 Q4 | -1.83 Million AUD | -196.33% |
| 2019 Q3 | -620.19 Thousand AUD | 59.41% |
| 2018 Q2 | -493.73 Thousand AUD | 0.0% |
| 2018 Q3 | -430.48 Thousand AUD | 12.81% |
| 2018 Q4 | -1.1 Million AUD | -156.31% |
| 2018 FY | - AUD | -2114.2% |
| 2017 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Australian Clinical Labs Limited | 181.83 Million AUD | 103.737% |
| BCAL Diagnostics Limited | -5.66 Million AUD | -19.924% |
| Genetic Signatures Limited | -20.33 Million AUD | 66.585% |
| Genetic Technologies Limited | -11.43 Million AUD | 40.547% |
| Healius Limited | -298.09 Million AUD | 97.72% |
| Imagion Biosystems Limited | -13.69 Million AUD | 50.383% |
| Integral Diagnostics Limited | 12.33 Million AUD | 155.099% |
| INOVIQ Ltd | -6.63 Million AUD | -2.45% |
| Microba Life Sciences Limited | -22.8 Million AUD | 70.205% |
| Monash IVF Group Limited | 13.02 Million AUD | 152.176% |
| Sonic Healthcare Limited | 1.65 Billion AUD | 100.41% |